-Takenori Ochiai Researcher Activity Profile

Research Author Detailed Information 

Takenori Ochiai Publication Rate By Year

Takenori Ochiai has published 17 paper(s) in 2007, 4 paper(s) in 2008, for a total of 21 research publications in total.

Takenori T Ochiai Author Information

LAST NAME: ochiai

FIRST NAME: takenori

INITIALS: T

AFFILIATION:

Papers

Takenori Ochiai's Publication Record

1. Detection of biomarkers for alcoholism by two-dimensional differential gel electrophoresis. Year Published: 2007
Department of Molecular Diagnosis (F8), Graduate School of Medicine, Chiba University, Chiba, Japan.
2. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice. Year Published: 2007
Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. yakutsu@faculty.chiba-u.jp
3. Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells. Year Published: 2007
Department of Frontier Surgery, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan.
4. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients. Year Published: 2007
Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
5. Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. Year Published: 2007
Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba 260-8677, Japan. k-hayano@graduate.chiba-u.jp
6. Intersegmental arterial communication between the medial and left lateral segments of the liver. Year Published: 2007
Department of Gastroenterological Surgery, Chiba Cancer Center Hospital, Chiba, Japan. acho@chiba-cc.jp
7. [Two cases treated with trastuzumab as primary chemotherapy] Year Published: 2007
Dept. of Frontier Surgery, Graduate School of Medicine, Chiba University.
8. Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3H3 mouse fibroblasts. Year Published: 2007
Departments of Frontier Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, Japan.
9. Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer. Year Published: 2007
Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan. K3126oji@aol.com
10. Evaluation of the hepatic blood flow increase in the cases with liver metastasis and prediction of patent cases of liver metastasis using dynamic CT. Year Published: 2007
Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. natsu-22@cameo.plala.or.jp
11. Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer. Year Published: 2007
Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan. K3126oji@aol.com
12. [Two cases treated with trastuzumab as primary chemotherapy] Year Published: 2007
Dept. of Frontier Surgery, Graduate School of Medicine, Chiba University.
13. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience. Year Published: 2007
Department of Frontier Surgery and the Research Center for Frontier Medical Engineering, Chiba University Graduate School of Medicine, Chiba, Japan.
14. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience. Year Published: 2007
Department of Frontier Surgery and the Research Center for Frontier Medical Engineering, Chiba University Graduate School of Medicine, Chiba, Japan.
15. Evaluation of the hepatic blood flow increase in the cases with liver metastasis and prediction of patent cases of liver metastasis using dynamic CT. Year Published: 2007
Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. natsu-22@cameo.plala.or.jp
16. Long-term Results after Dissection of Positive Thoracic Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma. Year Published: 2008
Department of Frontier Surgery, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan, hshimada@faculty.chiba-u.jp.
17. Intersegmental arterial communication between the medial and left lateral segments of the liver. Year Published: 2007
Department of Gastroenterological Surgery, Chiba Cancer Center Hospital, Chiba, Japan. acho@chiba-cc.jp
18. Detection of biomarkers for alcoholism by two-dimensional differential gel electrophoresis. Year Published: 2007
Department of Molecular Diagnosis (F8), Graduate School of Medicine, Chiba University, Chiba, Japan.
19. Hyperbaric oxygen therapy for the treatment of postoperative paralytic ileus and adhesive intestinal obstruction associated with abdominal surgery: experience with 626 patients. Year Published: 2008
Surgical Center, Chiba University Hospital, Chuo-ku, Chiba 260-8677, Japan. ambiru-s@umin.ac.jp
20. Improved Surgical Results in Thoracic Esophageal Squamous Cell Carcinoma: A 40-year Analysis of 792 Patients. Year Published: 2008
Department of Frontier Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuuou-ku, Chiba, 260-8670, Japan, hshimada@faculty.chiba-u.jp.
21. Ventral pancreatectomy associated with segmental duodenectomy including the major papilla. Year Published: 2008
Department of Surgery, Chiba Cancer Center Hospital, Chiba, Japan. acho@chiba-cc.jp